Israel - English - Ministry of Health

gamida care ltd., israel - alergens (chemical) 24 - plaster for provocation test - alergens (chemical) 24 - various - diagnosis of allergic contact dermatitis.

Singapore - English - HSA (Health Sciences Authority)

molnlycke health care asia-pacific pte ltd - general & plastic surgery - mepitel one is a wound contact layer designed for the management of a wide range of exuding wounds such as; skin tears, skin abrasions, surgical incisions, partial thickness burns, traumatic wounds, partial and full thickness grafts, radiated skin, leg and foot ulcers. it can also be used as a protective layer on non-exuding wounds, blisters and on areas with fragile skin.

Singapore - English - HSA (Health Sciences Authority)

molnlycke health care asia-pacific pte ltd - general hospital - mepitel film is intended to protect fragile and sensitive skin and minimize risk of skin breakdown. it can be used as secondary dressing, fixating e.g. gauze or nonwoven swabs or as a landing zone for aggressive tapes to secure devices to skin. it can be used as a protective dressing over iv sites when the iv device is secured through adhesive tape or sutures.

Singapore - English - HSA (Health Sciences Authority)

molnlycke health care asia-pacific pte ltd - general & plastic surgery - mepitel is a meshed non-adherent wound contact layer allowing passage of exudate and providing fixation and protection of tissues. mepitel is designed for a wide range of exuding wounds such as skin tears, skin abrasions, sutured wounds, second degree burns, lacerations, partial and full thickness grafts, diabetic ulcers, venous and arterial ulcers. mepitel can also be used as a protective layer on non-exuding wounds, blisters, fragile skin and exposed fragile tissues.

Singapore - English - HSA (Health Sciences Authority)

biomerieux singapore pte. ltd. - clinical chemistry - etest® is a manual, quantitative technique for the determination of antimicrobial susceptibility of non‑fastidious gram‑negative and gram‑positive aerobic bacteria and fastidious bacteria and yeasts and mould. the system comprises a predefined antibiotic gradient which is used to determine the minimum inhibitory concentration (mic, in μg/ml) of different antimicrobial agents against microorganisms tested on agar media after overnight incubation.

Singapore - English - HSA (Health Sciences Authority)

biomerieux singapore pte. ltd. - microbiology - etest is a quantitative technique for determining the antimicrobial susceptibility of gram-negative and gram-positive aerobic bacteria such as enterobacteriaceae, pseudomonas, staphylococcus and enterococcus species and fastidious bacteria, such as anaerobes, n. gonorrhoeae, s. pneumoniae, streptococcus and haemophilus species. the system comprises a predefined antibiotic gradient which is used to determine the minimum inhibitory concentration (mic), in μg/ml, of different antimicrobial agents against microorganisms as tested on agar media using overnight incubation."

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - somatropin, quantity: 5 mg/ml - diluent, not applicable - excipient ingredients: metacresol; water for injections - short stature due to decreased or failed secretion of pituitary growth hormone. indications as at 20 march 2001: short stature due to decreased or failed secretion of pituitary hormone. growth distrubances associated with gonadal dysgenesis (turner's syndrome). improvement of body composition and treatment of short stature associated with prader-willi syndrome (pws) in paediatric patients. indications as at 26 november 2001: short stature due to decreased or failed secretion of pituitary growth hormone. treatment of adults with severe growth hormone deficiency as diagnosed in the insulin tolerance test for growth hormone deficiency and defined by peak growth hormone concentrations of less than 2.5 nanograms/ml. growth disturbances associated with gonadal dysgenesis (turner's syndrome). improvement of body composition and treatment of short stature associated with prader-willi syndrome (pws) in paediatric patients. indications as at 13 june 2003: short stature due to decreased or failed secretion of pituit